Recall events
/
Event 92248
Event summary
Timeline bucket March 31, 2023
Product types Drug
Classifications Class II
Statuses Ongoing
Recalling firm wording Family Dollar Stores, Llc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
4 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 4
Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) packaged in a) 100-count bottles, b) 50-count bottles, and c) 3 (2 count) packets.
D-0563-2023
Recall number D-0563-2023
Initiated March 31, 2023
Classification Class II
Status Ongoing
Quantity Pending.
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP deviation
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP deviation: product outside labeled storage temperature requirements.
Code information SKUs a) 0901458; b) 0913023; c) 0999259 stored and distributed from DCs 07/28/2022 through 03/31/2023.
Distribution pattern Nationwide within the United States
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1031]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 4
Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) 24-count Caplets
D-0564-2023
Recall number D-0564-2023
Initiated March 31, 2023
Classification Class II
Status Ongoing
Quantity Pending
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP deviation
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP deviation: product outside labeled storage temperature requirements.
Code information SKU 0901839 stored and distributed from DCs 07/28/2022 through 03/31/2023.
Distribution pattern Nationwide within the United States
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4934]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 4
Advil Dual Action with Acetaminophen Acetaminophen 250 mg and Ibuprofen (NSAID) 125 mg Tablets Pain Reliever, 36 Caplets bottles
D-0565-2023
Recall number D-0565-2023
Initiated March 31, 2023
Classification Class II
Status Ongoing
Quantity Unavailable
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP deviation
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP deviation: product outside labeled storage temperature requirements.
Code information SKUs 0902867 stored and distributed from DCs 07/28/2022 through 03/31/2023.
Distribution pattern Nationwide within the United States
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1006]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 4
Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg Pain Reliever/Fever Reducer (NSAID) a) 20-count Liquid Filled Capsule bottles; b) 40-count Liquid Filled Capsule bottles.
D-0566-2023
Recall number D-0566-2023
Initiated March 31, 2023
Classification Class II
Status Ongoing
Quantity Pending
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP deviation
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP deviation: product outside labeled storage temperature requirements.
Code information SKUs a) 0999841; b) 0916071 stored and distributed from DCs 07/28/2022 through 03/31/2023.
Distribution pattern Nationwide within the United States
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[987]
FDA event record
· Exact recall-number query on openFDA
